Temperature and density dependent induction of a cytopathic effect following infection with non-cytopathic HAV strains

Virology

Volumn 430, Issue 1, 2012, Pages 30-42

  Wales, Samantha Q ^a   Ngo, Diana ^a   Hida, Kaoru ^a   Kulka, Michael ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Apoptosis; Cytopathic effect; Hepatitis A; RNase L

Indexed keywords

CASPASE 3; RIBONUCLEASE L; RIBOSOME RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DENSITY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; HUMAN CELL; INCUBATION TEMPERATURE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RNA CLEAVAGE; VIRUS CULTURE; VIRUS INDUCTION; VIRUS STRAIN;

ANIMALS; APOPTOSIS; CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; ENDORIBONUCLEASES; HEPATITIS A VIRUS; HUMANS; MACACA MULATTA; RNA, RIBOSOMAL; TEMPERATURE;

HEPATITIS A VIRUS;

EID: 84861833100     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.04.010     Document Type: Article

References (64)

1. Ali M.A Partial sequence at 2BC region of HAV isolated from stool of acute sporadic HAV patients. J Egypt. Public Health Assoc. 2002, 77:101-116.
2. Anderson D.A. Cytopathology, plaque assay, and heat inactivation of hepatitis A virus strain HM175. J. Med. Virol. 1987, 22:35-44.
3. Anderson D.A., Ross B.C., Locarnini S.A. Restricted replication of hepatitis A virus in cell culture: Encapsidation of viral RNA depletes the pool of RNA available for replication. J. Virol. 1988, 62:4201-4206.
4. Bedard K.M., Semler B.L. Regulation of picornavirus gene expression. Microbe. Infect./Inst. Pasteur 2004, 6:702-713.
5. Beneduce F., Pisani G., Divizia M., Pana A., Morace G. Complete nucleotide sequence of a cytopathic hepatitis A virus strain isolated in Italy. Virus Res. 1995, 36:299-309.
6. Binn L.N., Lemon S.M., Marchwicki R.H., Redfield R.R., Gates N.L., Bancroft W.H. Primary isolation and serial passage of hepatitis A virus strains in primate cell cultures. J. Clin. Microbiol. 1984, 20:28-33.
7. Bisbal C., Silverman R.H. Diverse functions of RNase L and implications in pathology. Biochimie 2007, 89:789-798.
8. Brack K., Frings W., Dotzauer A., Vallbracht A. A cytopathogenic, apoptosis-inducing variant of hepatitis A virus. J. Virol. 1998, 72:3370-3376.
9. Bradley D.W., Schable C.A., McCaustland K.A., Cook E.H., Murphy B.L., Fields H.A., Ebert J.W., Wheeler C., Maynard J.E. Hepatitis A virus: growth characteristics of in vivo and in vitro propagated wild and attenuated virus strains. J. Med. Virol. 1984, 14:373-386.
10. Castelli J.C., Hassel B.A., Maran A., Paranjape J., Hewitt J.A., Li X.L., Hsu Y.T., Silverman R.H., Youle R.J. The role of 2'-5' oligoadenylate-activated ribonuclease L in apoptosis. Cell Death Differ. 1998, 5:313-320.
11. Cayley P.J., Knight M., Kerr I.M. Virus-mediated inhibition of the ppp(A2'p)nA system and its prevention by interferon. Biochem. Biophys. Res. Commun. 1982, 104:376-382.
12. Cho M.W., Ehrenfeld E. Rapid completion of the replication cycle of hepatitis A virus subsequent to reversal of guanidine inhibition. Virology 1991, 180:770-780.
13. Cliver D.O. Early days of food and environmental virology. Food Environ. Virol. 2010, 2:1-23.
14. Cohen J.I., Rosenblum B., Feinstone S.M., Ticehurst J., Purcell R.H. Attenuation and cell culture adaptation of hepatitis A virus (HAV): A genetic analysis with HAV cDNA. J. Virol. 1989, 63:5364-5370.
15. Cromeans T., Fields H.A., Sobsey M.D. Replication kinetics and cytopathic effect of hepatitis A virus. J. Gen. Virol. 1989, 70:2051-2062. Pt 8.
16. Cromeans T., Sobsey M.D., Fields H.A. Development of a plaque assay for a cytopathic, rapidly replicating isolate of hepatitis A virus. J. Med. Virol. 1987, 22:45-56.
17. Daemer R.J., Feinstone S.M., Gust I.D., Purcell R.H. Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage. Infect. Immun. 1981, 32:388-393.
18. De Chastonay J., Siegl G. Replicative events in hepatitis A virus-infected MRC-5 cells. Virology 1987, 157:268-275.
19. Divizia M., Ruggeri F., Hentschel J., Flehmig B., Pana A., Perez-Bercoff R. Preliminary characterization of a fast-growing strain of human hepatitis A virus. Microbiologica 1986, 9:269-278.
20. Dotzauer A., Feinstone S.M., Kaplan G. Susceptibility of nonprimate cell lines to hepatitis A virus infection. J. Virol. 1994, 68:6064-6068.
21. Emerson S.U., McRill C., Rosenblum B., Feinstone S., Purcell R.H. Mutations responsible for adaptation of hepatitis A virus to efficient growth in cell culture. J. Virol. 1991, 65:4882-4886.
22. Fineschi N., Cavalieri F., Garelick H., Prugnola A., Pellegrini V., Zuckerman A.J. Characterization of a hepatitis A virus strain suitable for vaccine production. J. Hepatol. 1991, 13(Suppl 4):S146-151.
23. Fiore A.E. Hepatitis A transmitted by food. Clin. Infect. Dis. 2004, 38:705-715.
24. Flehmig B. Hepatitis A-virus in cell culture: I. Propagation of different hepatitis A-virus isolates in a fetal rhesus monkey kidney cell line (Frhk-4). Med. Microbiol. Immunol. 1980, 168:239-248.
25. Flehmig B. Hepatitis A virus in cell culture. II. Growth characteristics of hepatitis A virus in Frhk-4/R cells. Med. Microbiol. Immunol. 1981, 170:73-81.
26. Flehmig B., Vallbracht A., Wurster G. Hepatitis A virus in cell culture. III. Propagation of hepatitis A virus in human embryo kidney cells and human embryo fibroblast strains. Med. Microbiol. Immunol. 1981, 170:83-89.
27. Frösner G.G., Deinhardt F., Scheid R., Gauss-Müller V., Holmes N., Messelberger V., Siegl G., Alexander J.J. Propagation of human hepatitis A virus in a hepatoma cell line. Infection 1979, 7:303-305.
28. Funkhouser A.W., Purcell R.H., D'Hondt E., Emerson S.U. Attenuated hepatitis A virus: Genetic determinants of adaptation to growth in MRC-5 cells. J. Virol. 1994, 68:148-157.
29. Funkhouser A.W., Schultz D.E., Lemon S.M., Purcell R.H., Emerson S.U. Hepatitis A virus translation is rate-limiting for virus replication in MRC-5 cells. Virology 1999, 254:268-278.
30. Gaspar A.M., Vitral C.L., Yoshida C.F., Schatzmayr H.G. Primary isolation of a Brazilian strain of hepatitis A virus (HAF-203) and growth in a primate cell line (FRhK-4). Brazilian J. Med. Biolo. Res.=Revista brasileira de pesquisas medicas e biologicas/ Sociedade Brasileira de Biofisica... [et al.] 1992, 25:697-705.
31. Gauss-Müller V., Frösner G.G., Deinhardt F. Propagation of hepatitis A virus in human embryo fibroblasts. J. Med. Virol. 1981, 7:233-239.
32. Goswami B.B., Kulka M., Ngo D., Cebula T.A. Apoptosis induced by a cytopathic hepatitis A virus is dependent on caspase activation following ribosomal RNA degradation but occurs in the absence of 2'-5' oligoadenylate synthetase. Antiviral Res. 2004, 63:153-166.
33. Hollinger F.B.a.E.S.U. Hepatitis A Virus. Fields Virology 2001, 799-840. Lippincott Williams and Wilkins, Philadelphia, PA. 4th edn. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus (Eds.).
34. Jansen R.W., Newbold J.E., Lemon S.M. Combined immunoaffinity cDNA-RNA hybridization assay for detection of hepatitis A virus in clinical specimens. J. Clin. Microbiol. 1985, 22:984-989.
35. Jansen R.W., Newbold J.E., Lemon S.M. Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: Comparison with wild-type virus with restricted capacity for in vitro replication. Virology 1988, 163:299-307.
36. Jothikumar N., Cromeans T.L., Sobsey M.D., Robertson B.H. Development and evaluation of a broadly reactive TaqMan assay for rapid detection of hepatitis A virus. Appl. Environ. Microbiol. 2005, 71:3359-3363.
37. Kojima H., Shibayama T., Sato A., Suzuki S., Ichida F., Hamada C. Propagation of human hepatitis A virus in conventional cell lines. J. Med. Virol. 1981, 7:273-286.
38. Koopmans M., Duizer E. Foodborne viruses: An emerging problem. Int. J. Food Microbiol. 2004, 90:23-41.
39. Kulka M., Calvo M.S., Ngo D.T., Wales S.Q., Goswami B.B. Activation of the 2-5OAS/RNase L pathway in CVB1 or HAV/18f infected FRhK-4 cells does not require induction of OAS1 or OAS2 expression. Virology 2009, 388:169-184.
40. Kulka M., Chen A., Ngo D., Bhattacharya S.S., Cebula T.A., Goswami B.B. The cytopathic 18f strain of Hepatitis A virus induces RNA degradation in FrhK4 cells. Arch. Virol. 2003, 148:1275-1300.
41. Lemon S.M., Binn L.N., Marchwicki R.H. Radioimmunofocus assay for quantitation of hepatitis A virus in cell cultures. J. Clin. Microbiol. 1983, 17:834-839.
42. Lemon S.M., Murphy P.C., Shields P.A., Ping L.H., Feinstone S.M., Cromeans T., Jansen R.W. Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: Evidence for genetic recombination. J. Virol. 1991, 65:2056-2065.
43. Nainan O.V., Xia G., Vaughan G., Margolis H.S. Diagnosis of hepatitis a virus infection: A molecular approach. Clin. Microbiol. Rev. 2006, 19:63-79.
44. Nasser A.M., Metcalf T.G. Production of cytopathology in FRhK-4 cells by BS-C-1-passaged hepatitis A virus. Appl. Environ. Microbiol. 1987, 53:2967-2971.
45. Nilsen T.W., Maroney P.A., Baglioni C. Synthesis of (2'-5')oligoadenylate and activation of an endoribonuclease in interferon-treated HeLa cells infected with reovirus. J. Virol. 1982, 42:1039-1045.
46. Norder H., De Palma A.M., Selisko B., Costenaro L., Papageorgiou N., Arnan C., Coutard B., Lantez V., De Lamballerie X., Baronti C., Solà M., Tan J., Neyts J., Canard B., Coll M., Gorbalenya A.E., Hilgenfeld R. Picornavirus non-structural proteins as targets for new anti-virals with broad activity. Antiviral Res. 2011, 89:204-218.
47. Pellegrini V., Fineschi N., Matteucci G., Marsili I., Nencioni L., Puddu M., Garelick H., Zuckerman A.J. Preparation and immunogenicity of an inactivated hepatitis A vaccine. Vaccine 1993, 11:383-387.
48. Pinto R.M., Aragones L., Costafreda M.I., Ribes E., Bosch A. Codon usage and replicative strategies of hepatitis A virus. Virus Res. 2007, 127:158-163.
49. Player M.R., Torrence P.F. The 2-5A system: Modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacol. Therapeut. 78 1998, 55-113.
50. Provost P.J., Banker F.S., Giesa P.A., McAleer W.J., Buynak E.B., Hilleman M.R. Progress toward a live, attenuated human hepatitis A vaccine. Proc. Soc. Exp. Biol. Med. 1982, 170:8-14.
51. Provost P.J., Hilleman M.R. Propagation of human hepatitis A virus in cell culture in vitro. Proc. Soc. Exp. Biol. Med. 1979, 160:213-221.
52. Richards G.P., Watson M.A. Immunochemiluminescent focus assays for the quantitation of hepatitis A virus and rotavirus in cell cultures. J. Virol. Meth. 2001, 94:69-80.
53. Robertson B.H., Jansen R.W., Khanna B., Totsuka A., Nainan O.V., Siegl G., Widell A., Margolis H.S., Isomura S., Ito K., et al. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J. Gen. Virol. 1992, 73:1365-1377. Pt 6.
54. Ross B.C., Anderson D.A., Gust I.D. Hepatitis A virus and hepatitis A infection. Adv. Virus Res. 1991, 39:209-253.
55. Rusch L., Zhou A., Silverman R.H. Caspase-dependent apoptosis by 2',5'-oligoadenylate activation of RNase L is enhanced by IFN-beta. J. Interferon Cytokine Res.: The Off. J. Int. Soc. Interferon Cytokine Res. 2000, 20:1091-1100.
56. Siegl G., deChastonay J., Kronauer G. Propagation and assay of hepatitis A virus in vitro. J. Virol. Meth. 1984, 9:53-67.
57. Siegl G., Weitz M., Kronauer G. Stability of hepatitis A virus. Intervirology 1984, 22:218-226.
58. Silverman R.H., Skehel J.J., James T.C., Wreschner D.H., Kerr I.M. rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells. J. Virol. 1983, 46:1051-1055.
59. Simmonds R.S., Szucs G., Metcalf T.G., Melnick J.L. Persistently infected cultures as a source of hepatitis A virus. Appl. Environ. Microbiol. 1985, 49:749-755.
60. Vallbracht A., Hofmann L., Wurster K.G., Flehmig B. Persistent infection of human fibroblasts by hepatitis A virus. J. Gen. Virol. 1984, 65:609-615. Pt 3.
61. Venuti A., Di Russo C., del Grosso N., Patti A.M., Ruggeri F., De Stasio P.R., Martiniello M.G., Pagnotti P., Degener A.M., Midulla M. Isolation and molecular cloning of a fast-growing strain of human hepatitis A virus from its double-stranded replicative form. J. Virol. 1985, 56:579-588.
62. Wreschner D.H., James T.C., Silverman R.H., Kerr I.M. Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells. Nucleic Acids Res. 1981, 9:1571-1581.
63. Yeh H.Y., Hwang Y.C., Yates M.V., Mulchandani A., Chen W. Detection of hepatitis a virus by using a combined cell culture-molecular beacon assay. Appl. Environ. Microbiol. 2008, 74:2239-2243.
64. Zhou A., Paranjape J.M., Hassel B.A., Nie H., Shah S., Galinski B., Silverman R.H. Impact of RNase L overexpression on viral and cellular growth and death. J. Interferon Cytokine Res.: The Off. J. Int. Soc. Interferon Cytokine Res. 1998, 18:953-961.